Published in
American Thoracic Society, American Journal of Respiratory and Critical Care Medicine, 11(205), p. 1290-1299, 2022
DOI: 10.1164/rccm.202108-1859oc
Links
Tools
Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Journal article published in 2022 by
Gerard J. Criner,
Frederick M. Lang 
,
Robert L. Gottlieb ,
Kusum S. Mathews,
Tisha S. Wang,
Todd W. Rice,
Deepu Madduri,
Shashi Bellam,
Robert Jeanfreau,
Amy H. Case,
Marilyn K. Glassberg,
George Marshall Lyon,
Kareem Ahmad,
Robert Mendelson,
J. Michael DiMaio
and other authors.
,
Robert L. Gottlieb ,
Kusum S. Mathews,
Tisha S. Wang,
Todd W. Rice,
Deepu Madduri,
Shashi Bellam,
Robert Jeanfreau,
Amy H. Case,
Marilyn K. Glassberg,
George Marshall Lyon,
Kareem Ahmad,
Robert Mendelson,
J. Michael DiMaio
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 